AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 271 min read$ANIX

KUMAR AMIT purchased $11K of ANIX

KUMAR AMIT (Chief Executive Officer) purchased 3,188 shares of Anixa Biosciences Inc (ANIX) at $3.37 on 2026-07-27.

Original reporting
SEC EDGAR · KUMAR AMIT
Published Jul 27, 2026, 7:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ANIX
Bullish
medium confidence
Mentioned
$ANIX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANIXBullishLow
01

Why it matters

The only new information is the CEO’s reported open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may treat the filing as a small sentiment input, but it does not provide new guidance, trial results, or financing terms.

03

What to watch

The transaction is an open-market buy with no 10b5-1 plan and a small dollar amount, so traders should avoid over-weighting it versus upcoming clinical, financing, or earnings catalysts.

Relevance 4/10Novelty 5/10Timing: Filed 2026-07-27, same day as the reported purchase date.

Background

The article is a SEC Form 4 insider transaction disclosure for Anixa Biosciences, filed on 2026-07-27.

Company-level read

Ticker impact

$ANIXBullishMedium confidence
Context

CEO KUMAR AMIT filed a Form 4 open-market purchase of 3,188 shares at $3.37 on 2026-07-27.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and small.

Evidence & confidence

The filing is a primary-source insider transaction, but the disclosed size ($10.74k) is small relative to typical market-moving thresholds and includes no new company-specific operational or financial information.

Market effects

Sector

No direct sector read-through; this is a single-company insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider purchases can be routine (e.g., liquidity planning) and do not necessarily imply improved near-term fundamentals.

Key entities

  • issuer
    Anixa Biosciences Inc

    Subject of the Form 4 insider transaction disclosure.

  • insider
    KUMAR AMIT

    Chief Executive Officer and director who purchased shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ANIX insider trading history →

Related articles

SEP 11
$ANIXMedAI 8/10

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

finanznachrichten.de2 min
SEP 17
$INGMHighAI 8/10

PLATINUM EQUITY, LLC (Gores Tom) sold $53.5M of INGM (indirect holdings)

PLATINUM EQUITY, LLC sold 1,968,750 indirectly-held shares of Ingram Micro Holding Corp (INGM) at $27.19 ($53.53M total) on 2026-09-15. Filed jointly with Platinum Equity Investment Holdings, LLC (10% owner), Platinum Equity Investment Holdings IC (Cayman), LLC (10% owner), Platinum Equity InvestCo, L.P. (10% owner), Platinum Equity Investment Holdings V, LLC (10% owner), Platinum Equity Partners V, LLC (10% owner), Platinum Equity Partners V, L.P. (10% owner), Imola JV Holdings, L.P. (10% owner), Ingram Holdco, LLC (10% owner) and Gores Tom (10% owner).

SEC EDGAR1 min
SEP 17
$XBPLow

Avenue RP Opportunities Fund, L.P. (LASRY MARC) purchased $1.5M of XBP (indirect holdings)

Avenue RP Opportunities Fund, L.P. purchased 527,606 indirectly-held shares of XBP Global Holdings, Inc. (XBP) at $2.83 ($1.49M total) across 2 trades on 2026-09-15. Filed jointly with Avenue Global Dislocation Opportunities Fund, L.P. (10% owner), Avenue Europe International Management, L.P. (10% owner), Avenue Capital Management II, L.P. (10% owner), Avenue RP Opportunities Fund GenPar, LLC (10% owner), Avenue Global Dislocation Opportunities GenPar, LLC (10% owner), GL RP Partners, LLC (10% owner), GL Global Dislocation Opportunities Partners, LLC (10% owner) and LASRY MARC (10% owner).

SEC EDGAR1 min